Search research articles
Contact Us
Filters
Showing results (221-230 of 240) with videos related to
Page
of 24
Sort By:
Leukemia
|
March 4, 2005
No prognostic effect of additional chromosomal abnormalities in children with acute lymphoblastic leukemia and 11q23 abnormalities
A V Moorman, S C Raimondi, C H Pui, et al.
International Journal of Cancer
|
September 28, 2002
The kinetics of the visible growth of a primary melanoma reflects the tumor aggressiveness and is an independent prognostic marker: a prospective study
Jean Jacques Grob, Marie Aleth Richard, Johany Gouvernet, et al.
Blood
|
May 16, 2000
Treatment outcome in infant acute lymphoblastic leukemia. Children Leukemia Cooperative Group--EORTC. European Organization for Research and Treatment of Cancer
A Ferster, Y Benoit, N Francotte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1997
Systemic effect of intrathecal methotrexate during the initial phase of treatment of childhood acute lymphoblastic leukemia. The European Organization for Research and Treatment of Cancer Children's Leukemia Cooperative Group
A Thyss, S Suciu, Y Bertrand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 16, 2004
Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy
S de Botton, V Coiteux, S Chevret, et al.
Leukemia
|
September 2, 2005
Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group report
N Entz-Werle, S Suciu, J van der Werff ten Bosch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 3, 2001
Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial
F Millot, S Suciu, N Philippe, et al.
International Journal of Cancer
|
June 22, 2000
Delays in diagnosis and melanoma prognosis (I): the role of patients
M A Richard, J J Grob, M F Avril, et al.
Leukemia
|
March 4, 2005
Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG
J van der Werff Ten Bosch, S Suciu, A Thyss, et al.
International Journal of Cancer
|
June 22, 2000
Delays in diagnosis and melanoma prognosis (II): the role of doctors
M A Richard, J J Grob, M F Avril, et al.
Page
of 24
Search research articles
Search
Showing results (221-230 of 240) with videos related to
Sort By:
Page
of 24
Leukemia
|
March 4, 2005
No prognostic effect of additional chromosomal abnormalities in children with acute lymphoblastic leukemia and 11q23 abnormalities
A V Moorman, S C Raimondi, C H Pui, et al.
International Journal of Cancer
|
September 28, 2002
The kinetics of the visible growth of a primary melanoma reflects the tumor aggressiveness and is an independent prognostic marker: a prospective study
Jean Jacques Grob, Marie Aleth Richard, Johany Gouvernet, et al.
Blood
|
May 16, 2000
Treatment outcome in infant acute lymphoblastic leukemia. Children Leukemia Cooperative Group--EORTC. European Organization for Research and Treatment of Cancer
A Ferster, Y Benoit, N Francotte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1997
Systemic effect of intrathecal methotrexate during the initial phase of treatment of childhood acute lymphoblastic leukemia. The European Organization for Research and Treatment of Cancer Children's Leukemia Cooperative Group
A Thyss, S Suciu, Y Bertrand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 16, 2004
Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy
S de Botton, V Coiteux, S Chevret, et al.
Leukemia
|
September 2, 2005
Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group report
N Entz-Werle, S Suciu, J van der Werff ten Bosch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 3, 2001
Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial
F Millot, S Suciu, N Philippe, et al.
International Journal of Cancer
|
June 22, 2000
Delays in diagnosis and melanoma prognosis (I): the role of patients
M A Richard, J J Grob, M F Avril, et al.
Leukemia
|
March 4, 2005
Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG
J van der Werff Ten Bosch, S Suciu, A Thyss, et al.
International Journal of Cancer
|
June 22, 2000
Delays in diagnosis and melanoma prognosis (II): the role of doctors
M A Richard, J J Grob, M F Avril, et al.
Page
of 24